Asia Pacific Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Enzyme Type (Digestive Enzymes, Thrombolytic Enzymes, Hydrolases, and Endonucleases); Application (Disease Treatment, Diagnostic Tools, Biomedical Research, and Others)
Market Introduction
Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly. With the advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.
Thus, the significant increase in research and development activities is expected to create a significant demand for medical enzyme technology in the coming years, which is further anticipated to drive the medical enzyme technology market.
Following a string of pneumonia cases in Wuhan, the Chinese health authorities, the capital city of Hubei province (China), declared in January 2020 that these cases were caused by a novel coronavirus, officially known as extreme acute respiratory syndrome coronavirus (SARS-CoV)-2. In the initial outbreak in Wuhan, China, COVID-19 patients with digestive symptoms were found. In a descriptive, cross-sectional, multicenter study involving 204 COVID-19 patients validated by laboratory testing, 41.6% of COVID-19 patients reported nausea or vomiting, and 17.2% reported diarrhea. Importantly, patients with serious disease have a higher prevalence of diarrhea, nausea, or vomiting than those with mild disease. Another single-center study from a single hospital in Wuhan found that digestive symptoms are closely related to the severity of COVID-19. Diarrhea, nausea, vomiting, stomach pain, and anorexia were more common in patients admitted to the intensive care unit (ICU) than in those who were not moved to the ICU, and the prevalence of anorexia between the two groups was statistically significant, suggesting that it could be a strong predictor of a serious illness. Thus, the increasing demand for digestive enzymes is due to rising cases of COVID-19 is driving the growth of the market in the forecasted period.
Get more information on this report :
Market Overview and Dynamics
The Medical enzyme technology market in Asia Pacific is expected to grow from US$ 854.1 million in 2021 to US$ 1,385.6 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, and neurodegenerative disorders. They provide insight into the disease process by diagnosis, prognosis, and assessment of response therapy. Furthermore, many enzymes are used as diagnostic reagents in medical treatment. Due to the unique enzyme characteristics of specificity, high-catalytic efficiency, and mild action conditions, the enzymatic diagnosis has become a reliable, simple, and rapid diagnostic method. Because of their characteristics of remarkable curative effect and insignificant side effects, the medicinal enzymes have more and more applications in the healthcare sector, which is driving the medical enzyme technology market.
Key Market Segments
In terms of enzyme type, the hydrolases segment accounted for the largest share of the Asia Pacific medical enzyme technology market in 2020. In terms of application, the disease treatment segment accounted for the largest share of the Asia Pacific medical enzyme technology market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical enzyme technology market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck Kgaa, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc.
Reasons to buy report
- To understand the Asia Pacific Medical enzyme technology market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific Medical enzyme technology market
- Efficiently plan M&A and partnership deals in Asia Pacific Medical enzyme technology market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Medical enzyme technology market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
ASIA PACIFIC MEDICAL ENZYME TECHNOLOGY MARKET SEGMENTATION
By Enzyme Type
- Digestive Enzymes
- L-asparaginase
- Lactase
- Others
- Thrombolytic Enzymes
- Streptokinase
- Urokinase
- Others
- Hydrolases Enzymes
- Hyaluronidase
- Lysozymes
- Others
- Endonucleases Enzymes
- Benzonase
- Others
By Application
- Disease Treatment
- Diagnostic Tools
- Biomedical Research
- Others
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Medical Enzyme Technology Market – By Enzyme Type
1.3.2 Medical Enzyme Technology Market – By Application
1.3.3 Asia Pacific Medical Enzyme Technology Market – By Country
2. Asia Pacific Medical Enzyme Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Medical Enzyme Technology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Medical Enzyme Technology Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Medical Enzyme Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Applications of Enzymes in Diagnosis and Disease Treatment
5.1.2 Significant Increase in Research and Development Activities
5.2 Market Restraints
5.2.1 Handling and Safety Issues Related to Enzymes
5.3 Market Opportunities
5.3.1 Rising Production of Biopharmaceutical Products
5.4 Future Trends
5.4.1 Advancements in Enzyme Engineering
5.5 Impact Analysis
6. Medical Enzyme Technology Market – Asia Pacific Analysis
6.1 Asia Pacific Medical Enzyme Technology Market Revenue Forecasts and Analysis
7. Asia Pacific Medical Enzyme Technology Market Analysis and Forecasts To 2028 – By Enzyme Type
7.1 Overview
7.2 Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
7.3 Digestive Enzymes
7.3.1 Overview
7.3.2 Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 L-asparaginase Market
7.3.3.1 Overview
7.3.3.2 L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Lactase Market
7.3.4.1 Overview
7.3.4.2 Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Others Market
7.3.5.1 Overview
7.3.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Thrombolytic Enzymes
7.4.1 Overview
7.4.2 Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Streptokinase Market
7.4.3.1 Overview
7.4.3.2 Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Urokinase Market
7.4.4.1 Overview
7.4.4.2 Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others Market
7.4.5.1 Overview
7.4.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Hydrolases Enzymes
7.5.1 Overview
7.5.2 Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Hyaluronidase Market
7.5.3.1 Overview
7.5.3.2 Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Lysozymes Market
7.5.4.1 Overview
7.5.4.2 Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others Market
7.5.5.1 Overview
7.5.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Endonucleases
7.6.1 Overview
7.6.2 Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Benzonase
7.6.3.1 Overview
7.6.3.2 Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 Others
7.6.4.1 Overview
7.6.4.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Medical Enzyme Technology Market Analysis – By Application
8.1 Overview
8.2 Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
8.3 Disease Treatment
8.3.1 Overview
8.3.2 Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Tools
8.4.1 Overview
8.4.2 Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Biomedical Research
8.5.1 Overview
8.5.2 Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Medical Enzyme Technology Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 Asia Pacific
9.1.1 Overview
9.1.1.1 Asia Pacific: Medical Enzyme Technology Market, by Country, 2020 & 2028 (%)
9.1.1.2 China
9.1.1.2.1 China: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 China: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.2.2.1 China: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.2.2.2 China: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.2.2.3 China: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.1.2.2.4 China: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.2.3 China: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.1.3 Japan
9.1.1.3.1 Japan: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 Japan: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.3.2.1 Japan: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.3.2.2 Japan: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.3.2.3 Japan: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.1.3.2.4 Japan: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.3.3 Japan: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.1.4 India
9.1.1.4.1 India: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 India: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.4.2.1 India: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.4.2.2 India: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.4.2.3 India: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.1.4.2.4 India: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.4.3 India: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.1.5 South Korea
9.1.1.5.1 South Korea: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 South Korea: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.5.2.1 South Korea: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.5.2.2 South Korea: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.5.2.3 South Korea: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.1.5.2.4 South Korea: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.5.3 South Korea: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.1.6 Australia
9.1.1.6.1 Australia: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Australia: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.6.2.1 Australia: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.6.2.2 Australia: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.6.2.3 Australia: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.1.6.2.4 Australia: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.6.3 Australia: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.1.7 Rest of Asia Pacific
9.1.1.7.1 Rest of Asia Pacific: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2 Rest of Asia Pacific: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.1.7.2.1 Rest of Asia Pacific: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.1.7.2.2 Rest of Asia Pacific: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.1.7.2.3 Rest of Asia Pacific: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2.4 Rest of Asia Pacific: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.1.7.3 Rest of Asia Pacific: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Asia Pacific Medical Enzyme Technology Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done by Companies
12. COMPANY PROFILES
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novozymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Company Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Agilent Technologies, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Genzyme Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Promega Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cytiva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amano Enzyme Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 2. China: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 3. China: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 5. China: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 6. China: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 9. Japan: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 10. Japan: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. India: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 14. India: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 15. India: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 16. India: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 17. India: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 18. India: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 26. Australia: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 27. Australia: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 28. Australia: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 29. Australia: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 30. Australia: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. Glossary of Terms, Medical Enzyme Technology Market
LIST OF FIGURES
Figure 1. Medical Enzyme Technology Market Segmentation
Figure 2. Asia Pacific Medical Enzyme Technology Market Overview
Figure 3. Hydrolases Segment Held Largest Share of Enzyme Type in Medical Enzyme Technology Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Medical Enzyme Technology Market - Asia Pacific PEST Analysis
Figure 6. Medical Enzyme Technology Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Medical Enzyme Technology Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
Figure 9. Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
Figure 25. Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Medical Enzyme Technology Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. Asia Pacific: Medical Enzyme Technology Market, by Country, 2020 & 2028 (%)
Figure 31. China: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Japan: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. India: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. South Korea: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Australia: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Asia Pacific: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 38. Growth Strategies Done by the Companies in the Market, (%)
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific medical enzyme technology market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific medical enzyme technology market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the medical enzyme technology market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution